In 2023, the malignant neoplasms mortality rate in Spain stood at a standardized rate of X deaths per hundred thousand persons. The forecasted data for 2024 predict a rate of 179.0, followed by a downward trend in subsequent years: 177.7 (2025), 176.6 (2026), 175.7 (2027), and 174.9 (2028). This forecast suggests a gradual decrease in mortality rate over the next five years.
- Year-on-year variation shows the following patterns: - From 2024 to 2025, a decrease of approximately 0.7%. - From 2025 to 2026, a decrease of around 0.6%. - From 2026 to 2027, the rate continues to fall by about 0.5%. - From 2027 to 2028, the decrement is about 0.5%. - The five-year compound annual growth rate (CAGR) suggests an average annual decline of about 0.6%.
Future trends to watch include potential impacts of improved medical technologies and healthcare policies, advances in early detection and treatment methods, and possible demographic shifts. Monitoring these factors will be crucial for understanding the trajectory of malignant neoplasms mortality in Spain beyond the forecast period.
